Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical value of PTEN in patients with superficial bladder cancer.

Urologia internationalis - 1 Jan 2008

Han Kyung Seok, Jeong In Gab, Joung Jae Young, Yang Seung Ok, Chung Jinsoo, Seo Ho Kyung, Kwon Kyung Suk, Park Weon Seo, Lee Kang Hyun

Abstract excerpt

INTRODUCTION: Frequent mutations or deletions of PTEN (phosphatase and tensin homolog deleted on chromosome 10) are reported in bladder cancer, while there are few studies which evaluated PTEN as a clinical prognostic parameter of superficial bladder cancer. We prospectively evaluated PTEN expres...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to PTEN gene
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to PTEN Phosphohydrolase

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 18480628
DOI: 10.1159/000127338

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18480628-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical value of PTEN in patients with superficial bladder cancer.PMID 18480628Read ↗

The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder.Semantic proximity Read ↗

PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancerSemantic proximity Read ↗

Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.Semantic proximity Read ↗

Somatic mutation of PTEN in bladder carcinoma.Semantic proximity Read ↗

PTEN expression in patients with carcinoma of the cervix and its association with p53, Ki-67 and CD31.Semantic proximity Read ↗

[Overexpression of PTEN gene inhibits proliferation of bladder transitional carcinoma cell line EJ].Semantic proximity Read ↗

In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.Semantic proximity Read ↗

Molecular analysis of PTEN and MXI1 in primary bladder carcinoma.Semantic proximity Read ↗

Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.Semantic proximity Read ↗

Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas.Semantic proximity Read ↗

[Mutation analysis of tumor suppressor gene PTEN in bone and soft tissue tumors].Semantic proximity Read ↗

Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.